Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Navigo Invest AB | NAVIGOSTAM | Apr 10, 2025 | 1.89 | +3.85 |
Navigo Invest Pref | NAVIGOPREF | Apr 10, 2025 | 89.80 | +3.22 |
NAXS | NAXS | Apr 10, 2025 | 51.40 | +4.94 |
NCAB Group | NCAB | Apr 10, 2025 | 42.10 | +2.23 |
NCC A | NCCA | Apr 10, 2025 | 167.50 | +1.21 |
NCC B | NCCB | Apr 10, 2025 | 167.40 | +1.03 |
Nederman Holding | NMAN | Apr 10, 2025 | 180.00 | +2.27 |
NEL | NELO | Apr 10, 2025 | 2.47 | +9.28 |
Nelly Group | NELLY | Apr 10, 2025 | 32.91 | +1.90 |
Neobo Fastigheter | NEOBO | Apr 10, 2025 | 14.76 | +6.49 |
Neola Medical | NEOLA | Apr 10, 2025 | 2.58 | 0.00 |
Neovici Holding B | NEOB | Apr 10, 2025 | 6.02 | -3.22 |
Nepa | NEPA | Apr 10, 2025 | 20.30 | +1.50 |
Net Insight B | NETIB | Apr 10, 2025 | 4.35 | +3.82 |
Netel | NETEL | Apr 10, 2025 | 10.38 | +1.76 |
NetJobs Group | NJOB | Apr 10, 2025 | 1.63 | -17.68 |
New Nordic Healthbrands | NNH | Apr 10, 2025 | 13.90 | +4.51 |
New Wave B | NEWAB | Apr 10, 2025 | 85.15 | +1.61 |
Newbury Pharmaceuticals | NEWBRY | Apr 10, 2025 | 3.36 | +0.60 |
Nexam Chemical Holding | NEXAM | Apr 10, 2025 | 2.84 | +4.03 |
Nexar Group | NXAR | Apr 10, 2025 | 0.96 | +16.97 |
NextCell Pharma AB | NXTCL | Apr 10, 2025 | 1.18 | -3.75 |
NFO Drives | NFO | Apr 10, 2025 | 22.00 | +22.22 |
Ngenic | NGENIC | Apr 10, 2025 | 0.11 | +2.27 |
NGS Group | NGS | Apr 10, 2025 | 3.15 | +1.61 |
Nibe Industrier B | NIBEB | Apr 10, 2025 | 33.55 | +1.45 |
Nicoccino Holding | NICO | Apr 10, 2025 | 1.92 | -4.95 |
Nidhogg Resources Holding AB | NIDHOG | Apr 10, 2025 | 6.00 | +5.26 |
Nilsson Special Vehicles | NILS | Apr 10, 2025 | 2.88 | 0.00 |
Nilörngruppen B | NILB | Apr 10, 2025 | 57.00 | +0.53 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.